PMC Transactions

The Life Sciences Deal Finder

PMC helps Pharma, Healthcare and Life Sciences companies identify buyers, targets, investors and strategic partners through specialist M&A advisory and controlled Deal Discovery.

Find opportunities Submit a mandate Discuss a transaction

Life Sciences onlyPharma, Healthcare, Biotech, MedTech, Diagnostics and Consumer Health.

Controlled accessPublic teaser first. Confidential information only after agreement and approval.

Transaction-drivenBuyers are guided toward call, CI request, NBO, LOI or a clear decision.

Three ways to work with PMC

For companies that want to grow, sell, acquire, divest or partner in Life Sciences.

PMC focuses on the hard part of specialist transactions: identifying relevant counterparties, qualifying interest and moving the dialogue from vague market visibility to concrete transaction intent.

For sellers

Find the right buyer without losing control.

PMC supports shareholders, entrepreneurs, corporates and portfolio owners in confidential sale, divestment, brand, asset and partnering processes.

Sell-side route

For buyers

Turn acquisition criteria into qualified dealflow.

Strategic buyers, serial acquirers, private equity investors and family offices use PMC for focused target search, market mapping and origination.

Buy-side route

For investment banks, advisors and brokers

Extend reach through specialist healthcare matching.

PMC can support investment banks, M&A advisors and business brokers as specialist scout, matchmaker or platform partner while respecting mandate ownership, confidentiality and agreed permissions.

Cooperation route

Deal Discovery Platform

A curated transaction platform, not a public deal board.

Public examples show the PMC screening format. Real opportunities are routed selectively after registration, matching profile review and access approval. Confidential material is released only after agreement coverage and PMC approval.

Explore Deal Discovery Request access

Teaser

Screen fit first

Buyers assess public, non-confidential opportunity signals before requesting access.

Profile

Match relevance

Buyer criteria, sector focus, geography, scale and rationale improve future routing.

Release

Protect confidential material

CIMs and sensitive documents stay controlled until agreement and admin approval.

Follow-up

Keep the process moving

Interest becomes a next step: call, CI request, NBO, LOI, continue or decline.

Zug lake panorama with old town, Swiss mountains and international business setting

Zug, Switzerland

Discreet Swiss base, international Life Sciences reach.

Zug stands for stability, discretion and international business access. Located in one of Switzerland's most connected Life Sciences environments, PMC is close to pharmaceutical headquarters, biotech networks, investors and corporate decision makers while keeping the public presentation reserved and the transaction platform protected.

Why PMC

Specialist advisory with a controlled transaction infrastructure behind it.

PMC combines sector-specific judgement with workflows for records, teaser preparation, CIM generation, matching, Deal Room access, activity logging and follow-up.

Sector focus

Life Sciences only

Pharma, Healthcare and Life Sciences transactions require sharper terminology, buyer logic and confidentiality discipline.

Deal finder

Targets, buyers and partners

Research-driven origination for sellers, buyers, investors, advisors and strategic growth initiatives.

Advisory

Buy-side and sell-side execution

Mandate preparation, market approach, process support, confidential release, NBO, LOI and closing support.

Platform

No dead ends

The internal workflow is designed to show the next step until a buyer continues, schedules a call, submits an NBO or declines.

Next step

Choose the route that fits your objective.

Start with the route closest to your objective. PMC will review the inquiry and suggest the right transaction path.

Sell, divest or partner Acquire or invest Request Deal Discovery access Discuss first